Vaccination and herd immunity: what more do we know?

Current Opinion in Infectious Diseases
Harunor RashidRobert Booy

Abstract

This review summarizes herd immunity, focusing on conceptual developments with application to vaccination programs. The conventional idea of herd immunity is based on the relationship between the transmission dynamics of infectious agents and population immunity. However, there have been some recent conceptual developments in vaccine 'herd immunity' or 'herd protection' that address the complexities of imperfect immunity, heterogeneous populations, nonrandom vaccine uptake and 'freeloaders'. Some vaccines may provide better protection than others; for instance, meningococcal conjugate vaccines are superior to polysaccharide vaccines, as is true of pneumococcal and Haemophilus influenzae type b vaccines. Achieving a very high uptake rate should be the target for certain vaccines, for example, measles vaccine, in order to prevent the disease effectively. Emerging issues, for example, waning of immunity after pertussis vaccination, are fresh challenges. Herd immunity is a complex issue inherent to a vaccine and the population receiving the vaccine. We have more to learn and apply.

References

Nov 4, 1985·Nature·R M Anderson, R M May
Aug 31, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J TarangerJ B Robbins
Aug 9, 2003·Expert Review of Vaccines·Thomas May
Aug 26, 2003·Archives of Disease in Childhood·N S CrowcroftE Miller
Nov 25, 2003·Pediatric Research·Jeffrey P Baker, Samuel L Katz
Sep 18, 2004·BMJ : British Medical Journal·Jodie McVernonMary E Ramsay
Jun 28, 2005·Drugs·Janet R Casey, Michael E Pichichero
Sep 30, 2006·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·W Paul Glezen
Oct 24, 2006·Seminars in Pediatric Infectious Diseases·David O Matson
Oct 27, 2007·Tropical Medicine & International Health : TM & IH·Stephanie Dellicour, Brian Greenwood
Feb 15, 2008·The Journal of Infectious Diseases·Martin C J MaidenJames M Stuart
May 6, 2008·Archives of Disease in Childhood·J QuianT Verstraeten
Aug 6, 2008·Vaccine·Marie-Claude Bonnet, Anil Dutta
Oct 17, 2008·The Lancet Infectious Diseases·Evan J Anderson
Dec 5, 2008·Expert Review of Vaccines·Guilherme Gonçalves
Jun 23, 2009·Expert Review of Vaccines·Caroline L Trotter, Martin C J Maiden
Dec 1, 2009·Expert Review of Vaccines·Miguel O'Ryan, Alexandre C Linhares
Mar 11, 2010·JAMA : the Journal of the American Medical Association·Mark LoebStephen D Walter
Apr 16, 2010·Journal of the Royal Society, Interface·Michiel van BovenSusan Hahné
May 1, 1923·The Journal of Hygiene·W W Topley, G S Wilson
Jul 29, 2010·The Journal of Infectious Diseases·M Patricia Quinlisk
Feb 26, 2011·Archives of Disease in Childhood·Gulam KhandakerRobert Booy
Mar 24, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Paul FineDavid L Heymann
May 25, 2011·Scandinavian Journal of Infectious Diseases·Tae Hyong KimMark Loeb
May 28, 2011·The Lancet Infectious Diseases·John ClemensMohammad Ali
Jun 17, 2011·The Journal of Infectious Diseases·Robert Hall, Damien Jolley
Sep 1, 2011·The Journal of Infectious Diseases·Ben A LopmanUmesh D Parashar
Oct 5, 2011·The Journal of Infectious Diseases·Peter M StrebelStephen L Cochi
Oct 29, 2011·The Lancet Infectious Diseases·Michael T OsterholmEdward A Belongia
Dec 20, 2011·Vaccine·Mark MuscatUNKNOWN EUVAC.NET group
Jan 28, 2012·Expert Review of Pharmacoeconomics & Outcomes Research·Aurelie MillierSibilia Quilici

❮ Previous
Next ❯

Citations

Jul 18, 2015·Human Vaccines & Immunotherapeutics·Carla D Scarbrough LefebvreBaudouin Standaert
Jun 5, 2013·Human Vaccines & Immunotherapeutics·Sachiko Ozawa, Meghan L Stack
Oct 27, 2015·Archivum Immunologiae Et Therapiae Experimentalis·Ilona DudekDariusz Szukiewicz
Apr 29, 2015·Vaccine·Edward Mezones-HolguinVíctor J Suárez
Sep 18, 2012·Current Opinion in Microbiology·Ravi P N MishraFabio Bagnoli
Jan 31, 2017·Vaccines·Marco Cavallari, Gennaro De Libero
Jul 18, 2015·Scientific Reports·Shingo IwamiYoshio Koyanagi
Oct 30, 2016·The Journal of International Medical Research·Xin ChenChandini Raina MacIntyre
Dec 21, 2012·Expert Review of Vaccines·Mark H RozenbaumMaarten J Postma
Oct 26, 2013·Expert Review of Vaccines·Shousun Chen Szu
Jun 6, 2020·American Journal of Health Promotion : AJHP·David L KatzCandace D McNaughton
May 23, 2020·Vaccines·Vicente Javier Clemente-SuárezJose Francisco Tornero-Aguilera
Jun 20, 2020·American Journal of Health Promotion : AJHP·Candace D McNaughton
Nov 16, 2012·Expert Review of Vaccines·Arno Aj van der ArkCécile A C M van Els
Oct 5, 2016·Journal of Medical Ethics·Euzebiusz JamrozikMichael J Selgelid
Feb 12, 2017·BMC Health Services Research·Sachiko OzawaMary Qiu
Aug 14, 2020·European Journal of Epidemiology·Amiel A DrorEyal Sela
Apr 19, 2016·Annals of the American Thoracic Society·Andrew C BericalJennifer D Possick
Mar 30, 2018·Frontiers in Cellular and Infection Microbiology·Christian StutzerChristine Maritz-Olivier
Dec 17, 2014·The Journal of Pharmacy and Pharmacology·Charlotte N MaughanGareth R Williams
Jun 19, 2019·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Shamez N Ladhani, Mary E Ramsay
Apr 24, 2020·Wiener klinische Wochenschrift·Lisa WeitzWolfgang Maurer
Oct 27, 2020·Frontiers in Immunology·Ramachandran VigneshSadras Panchatcharam Thyagarajan
Jan 17, 2021·The Journal of Pediatrics·Jennifer DunnickParia M Wilson
Oct 31, 2020·Journal of Medical Internet Research·Hina HakimHolly O Witteman
Oct 26, 2016·Biochemical Pharmacology·Christopher P Karch, Peter Burkhard
Jul 3, 2021·Animals : an Open Access Journal From MDPI·Salleh Annas, Mohd Zamri-Saad
Aug 29, 2021·Vaccines·Najim Z AlshahraniHarunor Rashid
Aug 24, 2021·Journal of Theoretical Biology·Françoise KempStefano Magni
Sep 24, 2021·Human Vaccines & Immunotherapeutics·Saeed Ur RahmanMuhammad Iqbal Khan
Oct 9, 2021·Scientific Reports·Yanchao WangDaniel T O'Brien

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.